基本信息
views: 393
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Srdan Verstovsek, MD, PhD, serves as Professor of Medicine in the Department of Leukemia at the University of Texas MD Anderson Cancer Center. He is the Founder and Director of the Clinical Research Center for Myeloproliferative Neoplasms (MPNs) at MD Anderson and a global leader in this group of diseases. Dr Verstovsek's clinical and translational research is focused on understanding the biology of and developing new therapies for MPNs. He led the clinical development of landmark therapeutics for MPNs, and has been principal investigator for more than 60 clinical trials testing novel therapies for MPN. Dr Verstovsek has published more than 500 articles in prominent medical journals. His contributions have been globally recognized with awards and invitations as an expert lecturer at national and international conferences.
Research Interests
Papers共 1664 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
HAEMATOLOGICAno. 2 (2024): 676-681
Haematologicano. 4 (2024): 3010-3010
American journal of hematologyno. 7 (2024): 1434-1436
NEJM evidenceno. 6 (2024): EVIDoa2300362-EVIDoa2300362
Haematologicano. 1 (2024)
EJHaemno. 1 (2024): 105-116
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Researchno. 5 (2024): 607-613
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn